Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor‐negative breast cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-277x|28|3|272-282

ISSN： 0952-3871

Source： JOURNAL OF HUMAN NUTRITION & DIETETICS (ELECTRONIC), Vol.28, Iss.3, 2015-06, pp. : 272-282

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Randomised Trial: One Cycle of Anthracycline-Containing Adjuvant Chemotherapy Compared with Six Cycles of CMF Treatment in Node-Positive, Hormone Receptor-Negative Breast Cancer Patients

By  

Oncology Research and Treatment, Vol. 26, Iss. 2, 2003-05 ,pp. : 115-119

Karger

Access to resources Recommend Favorite

Benefit of adjuvant radiotherapy after breast‐conserving therapy among elderly women with T1‐T2N0 estrogen receptor‐negative breast cancer

By  

CANCER, Vol. 122, Iss. 19, 2016-10 ,pp. : 3059-3068

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Role of the Epidermal Growth Factor Receptor in Breast Cancer

By Chan Samuel   Hill Mark   Gullick William  

Journal of Mammary Gland Biology and Neoplasia, Vol. 11, Iss. 1, 2006-01 ,pp. : 3-11

Springer Publishing Company

Access to resources Recommend Favorite

MICAL2 promotes breast cancer cell migration by maintaining epidermal growth factor receptor (EGFR) stability and EGFR/P38 signalling activation

By  

ACTA PHYSIOLOGICA (ELECTRONIC), Vol. 222, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Estrogen Receptor-Positive and Estrogen Receptor-Negative Human Breast Cancer Cells: Regulation of Expression of Cancer-Related Genes by Estradiol and Tamoxifen

By  

Current Signal Transduction Therapy, Vol. 3, Iss. 1, 2008-01 ,pp. : 7-21

Bentham Science Publishers

Access to resources Recommend Favorite